SKN 33.3% 0.4¢ skin elements limited

SKN Webinar, page-12

  1. 365 Posts.
    lightbulb Created with Sketch. 24
    I think regardless of whether the product is good or not, the track record of achieving product sales is second to just about everyone.

    $20m in hot air research and development with barely a marketable product is bamboozling and as a tax payer funding the majority of this R&D, it is quite an astounding waste of money on the part of the government. Management will never hold themselves to account for the very poor performance. Seriously ,how much R&D can you do on sunscreen ,which is what he says is the main part in the development.

    The government wants high vaccination rates by the end of the year for us to open up. I can't imagine that demand for sanitiser will be going up at any stage. Too many other companies will have market reach in this market that these clowns will never hope to achieve .
 
watchlist Created with Sketch. Add SKN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.